Direct oral anticoagulants or low-molecular-weight heparins for venous thromboembolism in patients with brain tumors
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Direct oral anticoagulants or low-molecular-weight heparins for venous thromboembolism in patients with brain tumors
Authors
Keywords
Brain neoplasms, Factor Xa inhibitors, Heparin, Low-molecular-weight, Hemorrhage, Venous thromboembolism
Journal
THROMBOSIS RESEARCH
Volume 208, Issue -, Pages 148-155
Publisher
Elsevier BV
Online
2021-10-29
DOI
10.1016/j.thromres.2021.10.023
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer
- (2020) Giancarlo Agnelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of intracranial bleeding in patients with primary brain cancer receiving therapeutic anticoagulation for venous thromboembolism: A meta‐analysis
- (2020) Angelo Porfidia et al. Brain and Behavior
- Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update
- (2019) Nigel S. Key et al. JOURNAL OF CLINICAL ONCOLOGY
- Apixaban and dalteparin in active malignancy‐associated venous thromboembolism: The ADAM VTE trial
- (2019) Robert D. McBane et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)
- (2018) Annie M. Young et al. JOURNAL OF CLINICAL ONCOLOGY
- Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
- (2018) Gary E. Raskob et al. NEW ENGLAND JOURNAL OF MEDICINE
- Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): A systematic review and meta-analysis
- (2018) Ang Li et al. THROMBOSIS RESEARCH
- Intracranial hemorrhage with direct oral anticoagulants in patients with brain tumors
- (2018) B. J. Carney et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Venous thromboembolism and intracranial hemorrhage after craniotomy for primary malignant brain tumors: a National Surgical Quality Improvement Program analysis
- (2017) Joeky T. Senders et al. JOURNAL OF NEURO-ONCOLOGY
- Antithrombotic Therapy for VTE Disease
- (2016) Clive Kearon et al. CHEST
- A meta-analysis of intracranial hemorrhage in patients with brain tumors receiving therapeutic anticoagulation
- (2016) J. I. Zwicker et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Risk of intracranial hemorrhage associated with therapeutic anticoagulation for venous thromboembolism in cancer patients: a systematic review and meta-analysis
- (2016) Cristhiam M. Rojas-Hernandez et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Intracranial hemorrhage in cancer patients treated with anticoagulation
- (2016) Matthew J. Weinstock et al. THROMBOSIS RESEARCH
- Intracranial hemorrhage in patients with brain metastases treated with therapeutic enoxaparin: a matched cohort study
- (2015) J. Donato et al. BLOOD
- PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma
- (2010) J. R. PERRY et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Venous thromboembolism in malignant gliomas
- (2009) E. O. JENKINS et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search